Axonics Modulation Technologies Stock Shares Outstanding

AXNX Stock

USD 70.28 0.01 0.01%

Axonics Modulation Technologies fundamentals help investors to digest information that contributes to Axonics Modulation's financial success or failures. It also enables traders to predict the movement of Axonics Stock. The fundamental analysis module provides a way to measure Axonics Modulation's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axonics Modulation stock.

Short Long Term Debt Total Total Assets

Common Stock Shares Outstanding is likely to drop to about 34.2 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Axonics Modulation Technologies Company Shares Outstanding Analysis

Axonics Modulation's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Axonics Modulation Shares Outstanding

51.12 M

Most of Axonics Modulation's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axonics Modulation Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Axonics Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Axonics Modulation is extremely important. It helps to project a fair market value of Axonics Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Axonics Modulation's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Axonics Modulation's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Axonics Modulation's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Long Term Debt Total	Capital Surpluse	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Net Receivables	Net Invested Capital	Net Working Capital	Short Long Term Debt	Capital Stock	Short Term Debt	Deferred Long Term Liab
Total Assets		0.94	0.92	-0.78	-0.96	0.83	0.86	0.84	0.94	0.76	0.98	0.87	0.97	0.88	0.88	0.99	0.98	0.97	0.96	0.2	-0.69
Total Stockholder Equity	0.94		0.98	-0.71	-0.99	0.93	0.9	0.79	1.0	0.69	0.94	0.9	0.93	0.86	0.96	0.96	0.96	0.91	0.93	0.18	-0.82
Net Tangible Assets	0.92	0.98		-0.74	-0.97	0.95	0.95	0.85	0.98	0.62	0.95	0.8	0.94	0.91	0.93	0.95	0.97	0.9	0.88	0.29	-0.79
Net Debt	-0.78	-0.71	-0.74		0.77	-0.54	-0.8	-0.83	-0.69	-0.46	-0.82	-0.59	-0.84	-0.84	-0.55	-0.81	-0.8	-0.82	-0.65	-0.48	0.24
Retained Earnings	-0.96	-0.99	-0.97	0.77		-0.92	-0.89	-0.79	-0.99	-0.75	-0.96	-0.89	-0.94	-0.87	-0.95	-0.97	-0.97	-0.95	-0.94	-0.22	0.78
Accounts Payable	0.83	0.93	0.95	-0.54	-0.92		0.85	0.69	0.95	0.62	0.85	0.75	0.83	0.78	0.95	0.85	0.88	0.81	0.85	0.29	-0.87
Long Term Debt	0.86	0.9	0.95	-0.8	-0.89	0.85		0.95	0.89	0.39	0.91	0.68	0.95	0.98	0.78	0.9	0.92	0.84	0.75	0.31	-0.6
Long Term Debt Total	0.84	0.79	0.85	-0.83	-0.79	0.69	0.95		0.77	0.32	0.89	0.57	0.94	0.98	0.62	0.88	0.89	0.81	0.68	0.33	-0.41
Capital Surpluse	0.94	1.0	0.98	-0.69	-0.99	0.95	0.89	0.77		0.71	0.93	0.9	0.92	0.85	0.98	0.95	0.95	0.91	0.93	0.17	-0.84
Total Liab	0.76	0.69	0.62	-0.46	-0.75	0.62	0.39	0.32	0.71		0.69	0.78	0.59	0.41	0.78	0.71	0.68	0.72	0.84	0.07	-0.69
Total Current Assets	0.98	0.94	0.95	-0.82	-0.96	0.85	0.91	0.89	0.93	0.69		0.78	0.98	0.93	0.86	0.99	1.0	0.95	0.91	0.32	-0.68
Intangible Assets	0.87	0.9	0.8	-0.59	-0.89	0.75	0.68	0.57	0.9	0.78	0.78		0.78	0.65	0.89	0.85	0.8	0.83	0.92	-0.1	-0.73
Common Stock	0.97	0.93	0.94	-0.84	-0.94	0.83	0.95	0.94	0.92	0.59	0.98	0.78		0.96	0.82	0.98	0.98	0.94	0.88	0.3	-0.6
Property Plant Equipment	0.88	0.86	0.91	-0.84	-0.87	0.78	0.98	0.98	0.85	0.41	0.93	0.65	0.96		0.72	0.92	0.93	0.88	0.75	0.29	-0.52
Net Receivables	0.88	0.96	0.93	-0.55	-0.95	0.95	0.78	0.62	0.98	0.78	0.86	0.89	0.82	0.72		0.89	0.89	0.85	0.93	0.11	-0.92
Net Invested Capital	0.99	0.96	0.95	-0.81	-0.97	0.85	0.9	0.88	0.95	0.71	0.99	0.85	0.98	0.92	0.89		0.99	0.96	0.94	0.23	-0.69
Net Working Capital	0.98	0.96	0.97	-0.8	-0.97	0.88	0.92	0.89	0.95	0.68	1.0	0.8	0.98	0.93	0.89	0.99		0.96	0.92	0.3	-0.71
Short Long Term Debt	0.97	0.91	0.9	-0.82	-0.95	0.81	0.84	0.81	0.91	0.72	0.95	0.83	0.94	0.88	0.85	0.96	0.96		0.92	0.24	-0.62
Capital Stock	0.96	0.93	0.88	-0.65	-0.94	0.85	0.75	0.68	0.93	0.84	0.91	0.92	0.88	0.75	0.93	0.94	0.92	0.92		0.18	-0.76
Short Term Debt	0.2	0.18	0.29	-0.48	-0.22	0.29	0.31	0.33	0.17	0.07	0.32	-0.1	0.3	0.29	0.11	0.23	0.3	0.24	0.18		0.07
Deferred Long Term Liab	-0.69	-0.82	-0.79	0.24	0.78	-0.87	-0.6	-0.41	-0.84	-0.69	-0.68	-0.73	-0.6	-0.52	-0.92	-0.69	-0.71	-0.62	-0.76	0.07

Click cells to compare fundamentals

Axonics Shares Outstanding Historical Pattern

Today, most investors in Axonics Modulation Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Axonics Modulation's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Axonics Modulation shares outstanding as a starting point in their analysis.

Axonics Modulation Shares Outstanding

Timeline

Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Competition

Predict Axonics Modulation

Common Stock Shares Outstanding Over Time

Axonics Common Stock Shares Outstanding

Common Stock Shares Outstanding

34.15 Million

At this time, Axonics Modulation's Common Stock Shares Outstanding is fairly stable compared to the past year.

Based on the latest financial disclosure, Axonics Modulation Technologies has 51.12 M of shares currently outstending. This is 71.69% lower than that of the Health Care Equipment & Supplies sector and 70.78% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 91.06% higher than that of the company.

Axonics Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axonics Modulation's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axonics Modulation could also be used in its relative valuation, which is a method of valuing Axonics Modulation by comparing valuation metrics of similar companies.

Axonics Modulation is currently under evaluation in shares outstanding category among its peers.

Axonics Modulation Current Valuation Drivers

We derive many important indicators used in calculating different scores of Axonics Modulation from analyzing Axonics Modulation's financial statements. These drivers represent accounts that assess Axonics Modulation's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Axonics Modulation's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	105.7M	791.6M	1.8B	2.9B	3.1B	3.2B
Enterprise Value	30.9M	645.9M	1.6B	2.7B	3.0B	3.1B

Axonics Modulation ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Axonics Modulation's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Axonics Modulation's managers, analysts, and investors.

Environmental

Governance

Social

Axonics Fundamentals

	Return On Equity	-0.0028
	Return On Asset	-0.0046
	Profit Margin	(0) %
	Operating Margin	0.06 %
	Current Valuation	3.28 B
	Shares Outstanding	51.12 M
	Shares Owned By Insiders	1.27 %
	Shares Owned By Institutions	85.94 %
	Number Of Shares Shorted	3.6 M
	Price To Earning	(10.68) X
	Price To Book	5.58 X
	Price To Sales	8.79 X
	Revenue	366.38 M
	Gross Profit	197.66 M
	EBITDA	8.68 M
	Net Income	(6.09 M)
	Cash And Equivalents	213.23 M
	Cash Per Share	4.53 X
	Total Debt	27.62 M
	Debt To Equity	0.02 %
	Current Ratio	10.49 X
	Book Value Per Share	12.61 X
	Cash Flow From Operations	(2.02 M)
	Short Ratio	9.32 X
	Earnings Per Share	(0.02) X
	Price To Earnings To Growth	(0.56) X
	Target Price	71.73
	Number Of Employees	797
	Beta	0.82
	Market Capitalization	3.59 B
	Total Asset	719.92 M
	Retained Earnings	(380.35 M)
	Working Capital	445.61 M
	Current Asset	171.14 M
	Current Liabilities	12.98 M
	Net Asset	719.92 M

About Axonics Modulation Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Axonics Modulation Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axonics Modulation using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axonics Modulation Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
MSFT	Microsoft

Additional Tools for Axonics Stock Analysis

When running Axonics Modulation's price analysis, check to measure Axonics Modulation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axonics Modulation is operating at the current time. Most of Axonics Modulation's value examination focuses on studying past and present price action to predict the probability of Axonics Modulation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axonics Modulation's price. Additionally, you may evaluate how the addition of Axonics Modulation to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC